chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt got shivers and felt really cold after 2 hours of getting vaccination then vomiting started. She felt dizzy and had a headache. She felt her throat was getting hard and she had swelling. On 11/5/10 she feels ok but still does have slight headache and malaise.
Vasovagal response ~3 minutes after vaccination. Patient was lowered to the ground with assurance, has vitals checked. Blood pressure remained stable and oxygen saturation was maintained. Patient was observed for 30 minutes and reported improvement in symptoms. He was able to walk independently out of vaccination site.
Patient received both doses of the Pfizer COVID vaccine on 01/29/2021 and 02/22/2021. Patient tested positive for COVID on 03/12/2021. She was admitted on 03/14/2021 where she was diagnosed with Covid pneumonia with acute hypoxic respiratory failure. Discharged on 03/18/2021 Nursing & Rehab, where she died on 03/21/2021.
Left arm red and warm. No streaks noticed. Small cluster of blisters ( a few oozing clear liquid)
No adverse effects reported. FDA approved the 2023-2024 Monovalent COVID-19 vaccine and no longer authorized the Bivalent COVID-19 vaccine on 9-11-2023. ACIP meeting for approval was 9-12-2023. Patient was given the Bivalent COVID-19 vaccine on 9-13-2023, prior to knowing of the official change in recommendations. Patient notified by nurse to return in 2 months for the new monovalent 2023-2024 COVID-19 vaccine.
Hurt but worth it; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Hurt but worth it). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 23-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that, he/she did too. hurt but worth it. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Info has been received from a physician concerning a female pt who on 12/24/96 was vaccinated with a SC dose of varicella virus vaccine live. It was reported that the pt developed shingles. It was reported that at the time of the report, the pt has not recovered. It was noted that 2 children that she was exposed to, one 12 months old and the 7 months old, developed chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up info from a physician indicated that the pt developed zoster on her right upper leg on 3/21/05. The pt was treated with acyclovir and the rash cleared within 2 days. It was reported that the pt has fully recovered. No other info was provided. Additional info has been requested.
Hearing loss; Unilateral tinnitus; This is a spontaneous report from a contactable consumer (reporting for himself). A 22-year-old male patient received bnt162b2 (Lot Number: EP 7533), via an unspecified route of administration, administered in left arm on 11Apr2021 13:30 (at the age of 22-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 28Apr2021 12:00, the patient experienced unilateral tinnitus and hearing loss. The events resulted in disability or permanent damage.  Therapeutic measures were taken as a result of the events included prednisone 60mg 2-week taper. No covid prior vaccination nor covid tested post vaccination. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
girlfriend's dad arm was injured; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (RA).  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB INJURY (non-serious), outcome "unknown", described as "girlfriend's dad arm was injured".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Pt was seen on 10/30/04 with swelling and erythema of the al. aspect of right thigh with no tenderness. Area ~10cm in diameter. Pt did not show up for follow up
(L) upper arm mild/mod erythema, mild edema, tender, warm to touch, afebrile
I pretreated with 50 mg of Benadryl and Tylenol at 12:15. I got the injection at 01:41pm and at approx. 02:20 pm on my way home I developed hives and my throat started close up. I was taken to the ER. I was given .3 of epinephrine and then 60 mg of prednisone and 50 mg of Benadryl. Shortly after, about an hour later, my throat closed up again and I could not breathe. I was given an additional .3 of epi and more Benadryl and an IV was put in. I was discharged that evening with a 10mg taper of prednisone and 2 epi pens, I was directed to take Benadryl every 4-6 hours as needed. I have also had joint and muscle pain, a fever, sore arm. I am still itching, mostly in my face and left palm and left bottom of my foot.  I am unable to work, will have to stay home for a week to make sure this is resolved.
Develop symptoms the second day after vaccinated. She had nausea, vertigo, fatigue, hives, itching, shortness of breath, chest pain/ tachycardia, bruising on arm, fever.
muscle pain from injection site has remained but improved from the day before, slight headache which improved after sleep, severe chills - multiple blankets used including heating blanket used which improved after sleep
not feeling well; This case was reported by a other health professional via other manufacturer and described the occurrence of malaise in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included xeljanz.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced malaise. On an unknown date, the outcome of the malaise was unknown.   It was unknown if the reporter considered the malaise to be related to Shingrix.  Additional deatils were provided as follows: The age at vaccination was not reported. The age group was not reported but captured as adult as per vaccine indication. The patient was vaccinated with 1st dose of Shingrix and next day after vaccination patient was not feeling well. The patient was continued to hold Xeljanz as patient had Shingles since from June 2020 and treated for it. The physician ordered the patient to get the 2 doses of shingrix vaccine and at no plans to restart Xeljanz. No additional information provided.
Unusual, large swelling in both feet and lower legs within 3 hours of vaccination. Swelling was so intense in feet it bordered on painful.; Swelling was so intense in feet it bordered on painful.; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in left arm on 12Mar2021 19:30 (Lot Number: En6208) (at the age of 46-years-old) as 1st dose, single dose for covid-19 immunization. Medical history included hyperlipidaemia, high triglycerides, obesity, asthma and atopic dermatitis all from an unknown date and unknown if ongoing. The patient had known allergies for shellfish and latex. The patient did not receive other vaccines in four weeks. Concomitant medications included omega-3-acid ethyl ester (LOVAZA), rosuvastatin calcium (CRESTOR), vitamin d NOS and levocetirizine dihydrochloride (XYZAL), all  taken for an unspecified indication, start and stop date were not reported. The patient experienced unusual, large swelling in both feet and lower legs within 3 hours of vaccination on 12Mar2021 at 22:30. Swelling was so intense in feet it bordered on painful. The patient had no Covid prior to vaccination and had not been tested for COVID post vaccination. The outcome of the events was recovering.                         No follow-up attempts are possible. No further information is expected
Pt received Hep B, MMR, and PPD skin test. After receiving vaccines, pt began looking through personal folder in chair. Pt states to nurse "I feel light-headed." Pt became disoriented and incoherent. Pt assisted to reclining chair her feet elevated above heart. Pt became responsive later, and oriented person, time, and place. Pt given bottle of water, cheese/peanut butter crackers, and cool compress placed to forehead/neck. Pt monitored for 25 minutes B/P 115/72 HR = 72.
it was warm; it doesn't bother and can still see a ghost; large red lump/very small red lump to about 6 cm in diameter; injection site redness; injection site swelling; injection site pain; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (it was warm) and NIGHTMARE (it doesn't bother and can still see a ghost) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     The patient's past medical history included No adverse event (No medical history reported.).    On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (it was warm) and NIGHTMARE (it doesn't bother and can still see a ghost). At the time of the report, VACCINATION SITE WARMTH (it was warm) and NIGHTMARE (it doesn't bother and can still see a ghost) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: Follow up received on 22-Jan-2021 included patients date of Barth and patient experienced with some new event.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
PT called and left a message reporting subjective fever, chills, soreness around site injection and fatigue. He stated that is fever last from the evening of the shot until 0930 this morning of 8/17/18.
The morning after I got the vaccine, I woke up and felt fine.  Around noon I started to feel bad. By 2 o clock I was in bed. I stayed in bed the whole day. I felt really crappy for 5 days. The next week I felt like I had a cold with a running nose, headache, sinuses, and sore throat. I had a headache ever since I got the shot. I still can't get the headache to go away. I went to the doctor because of my headache and they told me to take Tylenol and Advil, but it still doesn't help the headaches.  I had a covid test that was negative and my bloodwork was fine. My doctor wants me to get a MRI of my head for my headaches.
vaccine was given at 6:40am and by midnight I had headache, chills and fever. By 7 am I had severe joint pain, muscle aches and my left arm pit was painful, swollen lymph node in my left arm pit and left neck. Fever and joint pain were gone by sunday. Then on monday night I came down with a bad chest cold, runny nose and cough and chills but no fever. Chest cold symptoms still present today 1/22/21.
dementia was exaggerated; Confused/mentally unwell; A spontaneous report was received from a consumer concerning an 84-year-old, female patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced, dementia was exaggerated (Dementia), confused/mentally unwell (Confusional state).  The patient's medical history included Covid-19 after first dose. Current conditions included underlying dementia. Concomitant product use was not provided by the reporter.  The patient received their first of two planned doses of mRNA-1273 (Batch number not provided) on an unknown date. On 01 Mar 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Batch number:011M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 01 Mar 2021, after receiving her second dose of vaccine, the patient was confused and mentally unwell. It was reported that after the vaccine, it seemed that her dementia was exaggerated.   Treatment for the events was not provided by the reporter.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.  The outcome of events, dementia was exaggerated and confused/mentally unwell was considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded. However, patient's elderly age along with underlying dementia may have been contributory.
Patient administered the second dose in series before the due date. First dose administered 10/1/2021 and second dose 10/15/2021.
Narrative:  56 YO M with PMH GERD, hypopituitarism, allergic rhinitis, DM, OSA reported blepharitis of right eye which developed within 18 hours of first COVID-19 vaccination on 3/9/21. Upper and lower lids swollen, red, and 2/10 painful, observed 3/18/21 with continued swelling and redness. Patient used OTC diphenhydramine and cold pack with slight improvement. Cephalexin tablets and tobramycin eye drops prescribed, however patient did not take as symptoms resolved the following day (3/19/21). Patient received second COVID-19 vaccination on 3/30/21, reaction did not reoccur. Does report slight GI upset (diarrhea, stomach ache) and possible irritation of left eye after second dose, but resolved within days without intervention.
Evening of injection, red spot on arm, soreness in arm.  Over past week, soreness traveled up left arm to left shoulder to left back, the area between backbone and shoulder.  Nagging pain has been worst in this upper left back area over past 4-5 days.  Have taken advil 3 times/day and used topical rubs and ice packs during this time with only temporary results
Intra-abdominal abscess. She was treated for an intra-abdominal abscess with IV zosyn and IV micafungin for about 2 weeks. We will continue to be followed by infectious disease at discharge with antibiotic management as per their recommendations. Hospital admission within 6 weeks of receiving the COVID vaccine.
Injection site was red and warm. Pt felt cold and also complained of body aches. Swelling at injection site.
From telephone contact with reporting nurse supervisot, it was stated that a 4 year old female patient received her 5th dose of Tripedia lot # UO532CA administered in the gluteal on 04/13/01. On 08/14/01, a large red area developed at the injection site. It resolved within a few days.
No additional adverse event; Nurse called to report that an expired dose of PROQUAD was administered to a patient.; This spontaneous report was received from a registered nurse referring to a 4-year-old male patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 21-APR-2022, the patient was vaccinated with first dose of measles, mumps, rubella, and varicella (OKA-MERCK) virus vaccine live recombinant human albumin (rHA) (PROQUAD) (valid lot #T034827, expiration date: 11-APR-2022) (expired vaccine used) (strength, dose, and route of administration were not provided) administered as prophylaxis. It was stated that the product had never experienced temperature excursion and had supported outcome. No adverse event was reported.
Palpitations; Increase in m yblood pressure; Had lymph nodes; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations), BLOOD PRESSURE INCREASED (Increase in m yblood pressure), LYMPHADENOPATHY (Had lymph nodes) and MYALGIA (Muscle pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Palpitations), BLOOD PRESSURE INCREASED (Increase in m yblood pressure), LYMPHADENOPATHY (Had lymph nodes) and MYALGIA (Muscle pain). At the time of the report, PALPITATIONS (Palpitations), BLOOD PRESSURE INCREASED (Increase in m yblood pressure), LYMPHADENOPATHY (Had lymph nodes) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Information has been received from a RN concerning a 4 year old female who on 08/17/92 was vaccinated with a first dose of MMRII (Lot # 603397/0260V).  Subsequently the pt experienced a "severe reaction".  Additional information has been requested.
After second Covid vaccine pain in both shoulders/upper arm and left hip bursitis increased from discomfort to pain .
the injection site is swollen; the injection site is itcy; the injection site is red.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (the injection site is swollen), VACCINATION SITE PRURITUS (the injection site is itcy) and VACCINATION SITE ERYTHEMA (the injection site is red.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (the injection site is swollen), VACCINATION SITE PRURITUS (the injection site is itcy) and VACCINATION SITE ERYTHEMA (the injection site is red.). At the time of the report, VACCINATION SITE SWELLING (the injection site is swollen), VACCINATION SITE PRURITUS (the injection site is itcy) and VACCINATION SITE ERYTHEMA (the injection site is red.) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Treatment medication not provided.  Concomitant medication not provided.   Reporter did not allow further contact
I has a bad rash that started in my head and then spread to my body. After a while the rash began to blister up. This went on for about 6weeks.
Patient has seizure disorder and was well controlled for 1.5 years prior to 1st Pfizer vaccine.  Patient experienced a seizure within 8 hours after receiving dose.  No report of fever.
sciatica; excruciating pain; her mobility is at 20%; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: Unknown), for COVID-19 Immunization, reaction(s): "she contracted covid in December". The following information was reported: SCIATICA (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "excruciating pain"; MOBILITY DECREASED (non-serious), outcome "unknown", described as "her mobility is at 20%".  Additional information: Please see below note Withheld received this morning. Passing along. To whom it may concern. Hi my name was Withheld and hoping you can point me in the right direction. Me and my wife got vaccinated last year with the Pfizer vaccine in the Withheld. She has been experiencing either both extreme or rare case of sciatica after she contracted COVID in December. She was 35 5'5 and 120 pounds she was by no means overweight and her diet was primarily gluten free products and balanced diet with supplements. She has been seeing a doctor at the Withheld location about 8 min away. They dont have any answers for her. Everyday she was in excruciating pain and her mobility was at 20%. was there any assistance or case studies that you provide that can point us down the right avenue. Any help would be greatly appreciated. Thanks and have a good day! Sincerely Withheld.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
NAUSEA; This spontaneous report received from a patient concerned a 37 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypertension, non smoker, and non alcohol user, and other pre-existing medical conditions included: The patient had no known allergies and did not had any drug abuse or illicit drug use. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 19-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 21-OCT-2021, the patient experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nausea. This report was non-serious. This report was associated with product quality complaint: 90000198612 .
Pt woke up midnight with left arm pain could not move arm above shoulder due to pain. Developed malaise pain down the arm. Diarrhea X 1 stool, Left deltoid warm to touch, Coldness in hand, Bilateral ankle joint pain
It started with a burning sensation on my scalp. I had a coworker and my mom looked at my scalp and saw nothing. My mom did see small bumps on my neck. I had nerve pain down my head to my neck, around my ear to my jaw, and my mouth. The doctors gave me medication. I am sleeping with an ice pack which helps with the itching. I am still having nerve pain and itchiness. I also had a rash on my scalp.